STAT+: House panel advances bill to extend Medicare’s telehealth flexibilities, setting up December talks
A House committee on Wednesday advanced legislation that would extend Medicare telehealth flexibilities and a…
Category: Biotech
STAT+: In race to make gene therapy for age-related blindness, 4D Molecular announces positive results
A long-running race to develop a gene therapy for the most common cause of age-related…
STAT+: Social media diss highlights high-stakes rivalry over colon cancer blood tests
Biotech companies routinely compete to develop and commercialize products. But these rivalries are seldom as…
STAT+: Hospital giant Ascension recorded about $1.3 billion in losses from its cyberattack
The cyberattack that forced Ascension to shut off access to its electronic health records cost…
Vance on ACA, diagnosing myopia, and fallout from a retracted study
In a story today from STAT’s Anil Oza, I learned that researcher and physician Alex…
Bernie Sanders keeps the heat on Novo’s high prices
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about pharma patent maneuvers, the U.S. warning J&J, and more
Hello, everyone, and how are you today? We are muddling along, but the middle of…
STAT+: Roivant strikes another deal, selling dermatology spinoff to Organon in deal worth $1.2 billion
Roivant Sciences continues its dealmaking hot streak, announcing Wednesday that it would sell one of…
Year-long fallout over retracted trans youth paper highlights new research era
Last year, a Springer Nature journal published a study surveying 1,700 parents of adolescents and…
Opinion: The U.S. should follow California’s lead on banning toxic chemicals in IV bags and tubes
In 2017, at the age of 42, Susan Whitehead was diagnosed with an early form…
Opinion: Tested in Africa, used in America
At the recent annual International AIDS Conference, a startling presentation about the newest wonder drug…
STAT+: Drugmakers rely on ‘use codes’ to vastly expand the nature of their patent claims, STAT analysis shows
Amid debate over potential abuse of the U.S. patent system by the pharmaceutical industry, moves…
FDA awards Novartis expanded approval for breast cancer therapy
Kisqali, a key targeted therapy for breast cancer from Novartis, until now has been indicated…
Senate IVF bill fails again as Democrats pressure GOP on reproductive health
WASHINGTON — The Senate failed again Tuesday to advance legislation that would protect access to…
Vance’s confusing health insurance remarks give Democrats a new attack line
GOP Vice Presidential-hopeful JD Vance made some confusing comments over the weekend about deregulating health…
STAT+: U.S. agency threatens J&J with sanctions if it switches payments to 340B hospitals
A U.S. government agency has threatened Johnson & Johnson with sanctions if the company proceeds…
STAT+: From Epic to FDA, all the leaders presenting at HHS’ invite-only AI in health care event
Federal health officials wrestling with when and how to use artificial intelligence will on Wednesday…
STAT+: Democrats keep IVF in the spotlight with another Senate vote
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
FDA formalizes protocol for international cancer trials
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about an Express Scripts lawsuit against FTC, AMR deaths, and more
Top of the morning to you, and a fine one it is, despite the gray…
STAT+: 11 people shaping psychedelics drug development
The field of psychedelics, once relegated to the fringes of science and medicine, is in…
STAT+: What pharma companies and insurers think about Medicare’s plan to cover digital treatments
In July, Medicare proposed to start paying for some mental health apps, in a move…
A documentary film asks: Can health systems improve patient safety by embracing new tech?
Reetam Ganguli once pitched his technology, to rescue women from pregnancy complications, in an airplane…
Opinion: WHO pandemic threat director: Here’s what needs to happen to combat mpox
There is a pervasive myth that the Democratic Republic of the Congo and other countries…
A history of mpox so far
Read Original Article: A history of mpox so far »
STAT+: Most cardiovascular devices with serious safety recalls aren’t tested in patients
When someone’s heart doesn’t beat quite right, an implantable defibrillator can save their life. The…
Could new childhood obesity guidelines fuel eating disorders?
Good morning! For a limited time, you can get your first three months of a…
The news from ESMO: An immunotherapy milestone, studying young-onset cancers, and more
This is the online edition of ESMO in 30 Seconds, a pop-up newsletter from the…
STAT+: What Medicare Advantage enrollment could look like for next year
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: After 10 years of game-changing immunotherapies, a cancer conference celebrates — and sees more work to do
BARCELONA, Spain — Ten years ago, a new type of cancer treatment reached the market….
STAT+: Top staffer on drug pricing to depart Senate Finance Committee
WASHINGTON – Shawn Bishop, the Democratic staffer who drafted much of the drug pricing portion…
STAT+: Pharmalittle: We’re reading about an AstraZeneca bladder cancer drug, Genentech anxiety, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
The essential biotech updates of the day
Morning! Today, we talk about bioethics, catch up on some reports from ESMO, and wonder aloud…
Pediatricians’ obesity guidelines rest on shaky evidence about eating disorder risks
To address soaring rates of childhood obesity, the American Academy of Pediatrics last year endorsed…
Q&A: The U.S. can, and should, do more on H5N1 bird flu, a top WHO official says
More work needs to be done by the agricultural sector to get to the bottom…
STAT+: Genentech, a biotech with a storied past, confronts new turbulence in the present
For decades, the biotech company Genentech has carved out a reputation in the industry as…
Opinion: End the ‘forced swim test’ on mice for antidepressant research
In 2022, more than 22 million Americans had serious thoughts of suicide or had made…
Opinion: What the doctors’ protests in India are missing
In early August, a doctor was raped and murdered in a Kolkata public hospital by…
STAT+: Exact Sciences reports initial positive results in colon cancer blood test, but pivot trial still pending
Exact Sciences, which has for years sold a stool-based colon cancer test, on Monday announced…
News from ESMO: An AstraZeneca win in bladder cancer, and more
This is the online edition of ESMO in 30 Seconds, a pop-up newsletter from the…
STAT+: AstraZeneca’s Imfinzi increases survival rates in bladder cancer in pivotal study
BARCELONA, Spain — An AstraZeneca immunotherapy, given both before and after surgery, improved survival rates…
STAT+: Checkpoint inhibitor staves off disease progression in anal cancer trial
BARCELONA, Spain — A widely used immunotherapy approach helped stave off disease progression in patients…
STAT+: Pfizer drug shows promise in cancer-related condition that causes weight loss and weakness
BARCELONA, Spain — Patients with advanced cancers often develop a secondary condition that causes them…
STAT+: BMS immunotherapy boosts responses in lung cancer, setting up Phase 3 study
BARCELONA, Spain — Adding a second immunotherapy from Bristol Myers Squibb to an existing checkpoint…
STAT+: Lung cancer drug from iTeos, GSK shows response, boosting TIGIT as a viable target
BARCELONA, Spain — A targeted immunotherapy being developed by the biotech iTeos Therapeutics and GSK…
The news from ESMO: The latest on anti-TIGIT data, a PD-(L)1 injection, and more
This is the online edition of ESMO in 30 Seconds, a pop-up newsletter from the…
Inquiry into unexplained bird flu case in Missouri broadens to a close contact
A close contact of the person in Missouri who had an unexplained H5 bird flu…
STAT+: FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug
Swiss pharma giant Roche won approval from the Food and Drug Administration on Friday for…
STAT+: ‘I’m still here’: Before Alzheimer’s, he prided himself on his intellect
Truck. Banana. Violin. Desk. Green. Sitting behind her desk in an examining room, the neurologist…
STAT+: Pharmalittle: We’re reading about Bavarian Nordic’s mpox shot, a crackdown on Ozempic prescribing and more
And so, another working week will soon draw to a close. Not a moment too…